Table 4.
Number | Japan | PRC | UK | US | ||||
---|---|---|---|---|---|---|---|---|
1145 | 839 | 497 | 2195 | |||||
VIM of average SBP of 1st and 2nd measurement across 4study visits | 5.44 | ± 2.88b | 6.85 | ± 3.49a,c | 5.65 | ± 2.81b | 5.84 | ± 3.01b |
VIM of 1st SBP measurement across 4 study visits | 6.14 | ± 3.15b | 7.20 | ± 3.62a,c | 6.10 | ± 2.97b | 6.39 | ± 3.22b,c |
VIM of 2nd SBP measurement across 4 study visits | 5.89 | ± 3.02b | 7.02 | ± 3.51a,c | 5.92 | ± 3.01b | 6.22 | ± 3.16b |
VIM of SBP of all measurement (8 times) | 5.92 | ± 2.53b,c | 6.76 | ± 3.13a,c | 5.82 | ± 2.53a,b | 6.14 | ± 2.67b,c, |
Values are number or mean ± SD
ANCOAVA was used to tests for differences of VIMs of BP among countries
Adjusted for age, sex, study centers, pulse, outside temperature, urinary potassium excretion, urinary sodium excretion, past history of CVD and antihypertensive medication drug class
Significantly different from Japan (Followed by Bonferroni post hoc testing)
Significantly different from PRC (Followed by Bonferroni post hoc testing)
Significantly different from UK (Followed by Bonferroni post hoc testing)
BP blood pressure, VIM variation independent of mean, SBP systolic blood pressure, PRC People’s Republic of China, UK United Kingdom, US United States, SD standard deviation, ANCOVA analysis of covariance